-
Startseite
-
a-t-Archiv
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Geschenkabo
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
 
Volume 38, 14 September 2007 9/2007
 
  NEW ON THE MARKET
 

A new anti-hypertensive drug: aliskiren (RASILEZ)

 
  THERAPY FROM A CRITICAL VIEWPOINT

Thiazide diuretics: first choice for diabetic patients with hypertension
What is the evidence for hip protectors?

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Testosterone patch INTRINSA for women after surgical castration?
ACE-inhibitors for coronary heart disease even without heart failure?
Strontium ranelate (PROTELOS): prevention of non-vertebral fractures proven?
Janssen-Cilag's comment on paliperidone (INVEGA)

 
  IN BRIEF
 

QTc-prolongation: clobutinol antitussives (e.g. SILOMAT) off market
Call for a register for doctor's fees from the industry

 
  CURRENT ADR NETWORK REPORT
 

Montelukast (SINGULAIR) and depression

 
  SIDE EFFECTS
 

Valproate (e.g. ORFIRIL): pubertas praecox and endocrine effects
Botulinum toxin (e.g. BOTOX): dysphagia, myasthenia and death

 
© arznei-telegramm 9/2007